Concurrent impairment of (Na++K+)-ATPase activity in multi-organ of type-1 diabetic NOD mice

Anderson, 2005, The NOD mouse: a model of immune dysregulation, Annual Review of Immunology, 23, 447, 10.1146/annurev.immunol.23.021704.115643 Atkinson, 1999, The NOD mouse model of type 1 diabetes: as good as it gets?, Nature Medicine, 5, 601, 10.1038/9442 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Burke, 2007, Aberrant endometrial features of pregnancy in diabetic NOD mice, Diabetes, 56, 2919, 10.2337/db07-0773 De La Tour, 1998, Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level, Diabetologia, 41, 1080, 10.1007/s001250051033 Ewart, 1995, Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity, American Journal of Physiology, 269, C295, 10.1152/ajpcell.1995.269.2.C295 Finotti, 1986, Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma, Diabetologia, 29, 623, 10.1007/BF00869260 Forst, 2000, Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type I, Clinical Science (London, England), 98, 283, 10.1042/CS19990241 Gale, 2002, Can we change the course of beta-cell destruction in type 1 diabetes?, The New England Journal of Medicine, 346, 1740, 10.1056/NEJM200205303462211 Geering, 2008, Functional roles of Na,K-ATPase subunits, Current Opinion in Nephrology and Hypertension, 17, 526, 10.1097/MNH.0b013e3283036cbf Greene, 1987, Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications, The New England Journal of Medicine, 316, 599, 10.1056/NEJM198703053161007 Hayward, 1999, Altered sodium pump alpha and gamma subunit gene expression in nephron segments from hypertensive rats, Journal of Hypertension, 17, 1081, 10.1097/00004872-199917080-00006 Jannot, 2002, Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients, Metabolism, 51, 284, 10.1053/meta.2002.29009 Jorgensen, 2003, Structure and mechanism of Na,K-ATPase: functional sites and their interactions, Annual Review of Physiology, 65, 817, 10.1146/annurev.physiol.65.092101.142558 Karounos, 2003, Utilization of NOD mice in the study of type 1 diabetes, Methods in Molecular Medicine, 83, 81 Kjeldsen, 1987, Diabetes decreases Na+-K+ pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat, Diabetes, 36, 842, 10.2337/diabetes.36.7.842 Kyte, 1971, Purification of the sodium- and potassium-dependent adenosine triphosphatase from canine renal medulla, Journal of Biological Chemistry, 246, 4157, 10.1016/S0021-9258(18)62067-8 Kyte, 1981, Molecular considerations relevant to the mechanism of active transport, Nature, 292, 201, 10.1038/292201a0 Lee, 2009, Activation of (Na+ + K+)-ATPase modulates cardiac L-type Ca2+ channel function, Molecular Pharmacology, 75, 774, 10.1124/mol.108.052597 Lingrel, 1994, Na+, K(+)-ATPase, Journal of Biological Chemistry, 269, 19659, 10.1016/S0021-9258(17)32067-7 Lucchesi, 1991, Postnatal changes in Na,K-ATPase isoform expression in rat cardiac ventricle. Conservation of biphasic ouabain affinity, Journal of Biological Chemistry, 266, 9327, 10.1016/S0021-9258(18)31589-8 Mathis, 2001, beta-Cell death during progression to diabetes, Nature, 414, 792, 10.1038/414792a Mazzanti, 1990, Altered cellular Ca2+ and Na+ transport in diabetes mellitus, Diabetes, 39, 850, 10.2337/diabetes.39.7.850 Morth, 2007, Crystal structure of the sodium-potassium pump, Nature, 450, 1043, 10.1038/nature06419 Muneyuki, 1993, Inhibitory effect of NaN3 on the F0F1 ATPase of submitochondrial particles as related to nucleotide binding, Biochimica et Biophysica Acta, 1144, 62, 10.1016/0005-2728(93)90031-A Ottlecz, 1993, Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats, Current Eye Research, 12, 1111, 10.3109/02713689309033509 Owada, 1999, Glucose decreases Na+, K+-ATPase activity in pancreatic beta-cells. An effect mediated via Ca2+-independent phospholipase A2 and protein kinase C-dependent phosphorylation of the alpha-subunit, Journal of Biological Chemistry, 274, 2000, 10.1074/jbc.274.4.2000 Prochazka, 1992, NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice, Diabetes, 41, 98, 10.2337/diabetes.41.1.98 Rabini, 1993, Alterations in Na+/K(+)-ATPase activity and fluidity of erythrocyte membranes from relatives of insulin dependent diabetic patients, Diabetes Research, 22, 33 Sagara, 1991, Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations, Journal of Biological Chemistry, 266, 13503, 10.1016/S0021-9258(18)92726-2 Sima, 1999, Experimental diabetic neuropathy: an update, Diabetologia, 42, 773, 10.1007/s001250051227 Skou, 1988, The Na,K-pump, Methods in Enzymology, 156, 1, 10.1016/0076-6879(88)56004-4 Smith, 1987, Monoclonal antibody localization of Na+-K+-ATPase in the exocrine pancreas and parotid of the dog, American Journal of Physiology, 253, G99 2000, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy, The New England Journal of Medicine, 342, 381, 10.1056/NEJM200002103420603 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, The New England Journal of Medicine, 329, 977, 10.1056/NEJM199309303291401 Vague, 2004, C-peptide, Na+, K(+)-ATPase, and diabetes, Experimental Diabesity Research, 5, 37, 10.1080/15438600490424514 Xu, 2005, Activation of (Na+ + K+)-ATPase, Biochemical and Biophysical Research Communications, 338, 1669, 10.1016/j.bbrc.2005.10.067